US Stock MarketDetailed Quotes

YS YS Biopharma

Watchlist

0.931
-0.049-4.98%

Trading May 22 10:49 ET

175.37MMarket Cap-2211P/E (TTM)

YS Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 31, 2023

(FY)Mar 31, 2022

(FY)Mar 31, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-5.14%-182.47M

29.63%-173.55M

-246.61M

Net income from continuing operations

-37.24%-145.48M

44.74%-106M

---191.83M

Operating gains losses

-107.80%-21.36K

1,001.39%273.98K

--24.88K

Depreciation and amortization

17.76%36.69M

11.64%31.15M

--27.91M

Deferred tax

-77.04%1.13M

-71.71%4.94M

--17.45M

Other non cash items

16.79%4.42M

69.61%3.79M

--2.23M

Change In working capital

25.77%-92.75M

33.08%-124.94M

---186.68M

-Change in receivables

-139.32%-165.25M

69.15%-69.05M

---223.82M

-Change in inventory

79.71%-18.15M

-30.16%-89.46M

---68.73M

-Change in prepaid assets

-84.82%8.99M

-59.64%59.23M

--146.77M

-Change in payables and accrued expense

536.95%92.66M

45.11%-21.21M

---38.63M

-Change in other current liabilities

-19.86%-4.55M

-70.83%-3.8M

---2.22M

-Change in other working capital

-881.77%-6.45M

-1,382.67%-656.67K

---44.29K

Cash from discontinued investing activities

Operating cash flow

-5.14%-182.47M

29.63%-173.55M

---246.61M

Investing cash flow

Cash flow from continuing investing activities

80.94%-56.98M

-186.77%-298.92M

-104.24M

Net PPE purchase and sale

82.16%-52.69M

-183.30%-295.31M

---104.24M

Net intangibles purchase and sale

-18.63%-4.29M

---3.62M

--0

Cash from discontinued investing activities

Investing cash flow

80.94%-56.98M

-186.77%-298.92M

---104.24M

Financing cash flow

Cash flow from continuing financing activities

-12.92%317.45M

-50.69%364.56M

739.26M

Net issuance payments of debt

-72.33%100.88M

4,315.43%364.56M

--8.26M

Net common stock issuance

--0

--1.59M

Net preferred stock issuance

--0

--729.41M

Net other financing activities

--216.57M

----

Cash from discontinued financing activities

Financing cash flow

-12.92%317.45M

-50.69%364.56M

--739.26M

Net cash flow

Beginning cash position

-30.58%271.07M

18,942.60%390.46M

--2.05M

Current changes in cash

172.28%78M

-127.78%-107.91M

--388.41M

Effect of exchange rate changes

285.60%21.3M

-429,159.95%-11.48M

---2.67K

End cash Position

36.63%370.37M

-30.58%271.07M

--390.46M

Free cash flow

49.31%-239.52M

-34.42%-472.48M

---351.49M

Currency Unit

CNY

Audit Opinions

Unqualified Opinion

	(FY)Mar 31, 2023	(FY)Mar 31, 2022	(FY)Mar 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-5.14%-182.47M	29.63%-173.55M	-246.61M
Net income from continuing operations	-37.24%-145.48M	44.74%-106M	---191.83M
Operating gains losses	-107.80%-21.36K	1,001.39%273.98K	--24.88K
Depreciation and amortization	17.76%36.69M	11.64%31.15M	--27.91M
Deferred tax	-77.04%1.13M	-71.71%4.94M	--17.45M
Other non cash items	16.79%4.42M	69.61%3.79M	--2.23M
Change In working capital	25.77%-92.75M	33.08%-124.94M	---186.68M
-Change in receivables	-139.32%-165.25M	69.15%-69.05M	---223.82M
-Change in inventory	79.71%-18.15M	-30.16%-89.46M	---68.73M
-Change in prepaid assets	-84.82%8.99M	-59.64%59.23M	--146.77M
-Change in payables and accrued expense	536.95%92.66M	45.11%-21.21M	---38.63M
-Change in other current liabilities	-19.86%-4.55M	-70.83%-3.8M	---2.22M
-Change in other working capital	-881.77%-6.45M	-1,382.67%-656.67K	---44.29K
Cash from discontinued investing activities
Operating cash flow	-5.14%-182.47M	29.63%-173.55M	---246.61M
Investing cash flow
Cash flow from continuing investing activities	80.94%-56.98M	-186.77%-298.92M	-104.24M
Net PPE purchase and sale	82.16%-52.69M	-183.30%-295.31M	---104.24M
Net intangibles purchase and sale	-18.63%-4.29M	---3.62M	--0
Cash from discontinued investing activities
Investing cash flow	80.94%-56.98M	-186.77%-298.92M	---104.24M
Financing cash flow
Cash flow from continuing financing activities	-12.92%317.45M	-50.69%364.56M	739.26M
Net issuance payments of debt	-72.33%100.88M	4,315.43%364.56M	--8.26M
Net common stock issuance	--0	--0	--1.59M
Net preferred stock issuance	--0	--0	--729.41M
Net other financing activities	--216.57M	----	----
Cash from discontinued financing activities
Financing cash flow	-12.92%317.45M	-50.69%364.56M	--739.26M
Net cash flow
Beginning cash position	-30.58%271.07M	18,942.60%390.46M	--2.05M
Current changes in cash	172.28%78M	-127.78%-107.91M	--388.41M
Effect of exchange rate changes	285.60%21.3M	-429,159.95%-11.48M	---2.67K
End cash Position	36.63%370.37M	-30.58%271.07M	--390.46M
Free cash flow	49.31%-239.52M	-34.42%-472.48M	---351.49M
Currency Unit	CNY	CNY	CNY
Audit Opinions	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall